Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 669–670 | Cite as

ASO Author Reflections: 21-Gene Recurrence Scores in Male Breast Cancer

  • Ariella M. Altman
  • Schelomo MarmorEmail author
ASO Author Reflections



The authors have no conflicts of interest to disclose.


  1. 1.
    Massarweh SA, Sledge GW, Miller DP, McCullough D, Petkov VI, Shak S. Molecular characterization and mortality from breast cancer in men. J Clin Oncol. 2018;36:1396–404.CrossRefGoogle Scholar
  2. 2.
    Giordano SH. Breast cancer in men. N Engl J Med. 2018;378:2311–20.CrossRefGoogle Scholar
  3. 3.
    Greif JM, Pezzi CM, Klimberg VS, Bailey L, Zuraek M. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base. Ann Surg Oncol. 2012;19:3199–204.CrossRefGoogle Scholar
  4. 4.
    Grenader T, Yerushalmi R, Tokar M, et al. The 21-gene recurrence score assay (Oncotype DX™) in estrogen receptor-positive male breast cancer: experience in an Israeli cohort. Oncology. 2014;87:1–6.CrossRefGoogle Scholar
  5. 5.
    Altman AM, Kizy S, Yuan J, et al. Distribution of 21-gene recurrence scores in male breast cancer in the United States. Ann Surg Oncol. 2018;25:2296–302.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of MinnesotaMinneapolisUSA

Personalised recommendations